Form 4: Nuvalent CLO Sells Shares After Option Exercise

Nuvalent's Chief Legal Officer, Deborah Ann Miller, exercised stock options and subsequently sold a portion of the acquired Class A Common Stock under a pre-arranged 10b5-1 trading plan.

Summary

• Deborah Ann Miller, Chief Legal Officer of Nuvalent, Inc., engaged in transactions involving the company's Class A Common Stock.
• The transactions occurred on October 15, 2025, and October 16, 2025.
• All reported transactions were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2024.
• On October 15, 2025, Miller acquired 15,624 shares of Class A Common Stock by exercising stock options at a price of $6.89 per share.
• Also on October 15, 2025, Miller sold 15,624 shares of Class A Common Stock at a weighted average price of $89.98.
• On October 16, 2025, Miller acquired 12,376 shares of Class A Common Stock by exercising stock options at a price of $6.89 per share.
• On October 16, 2025, Miller sold a total of 12,376 shares of Class A Common Stock across multiple transactions at weighted average prices ranging from $90.54 to $92.50.
• Following these reported transactions, Deborah Ann Miller directly beneficially owns 49,086 shares of Class A Common Stock.
• Miller also directly beneficially owns 145,608 stock options (right to buy) after these transactions, with the exercised options being fully vested.

Sentiment

Score: 7

Explanation: The filing reports routine insider transactions (option exercise and sale) executed under a pre-arranged 10b5-1 plan. The executive realized significant gains from exercising options at a low strike price and selling shares at a much higher market price, which is a positive for the individual. For the company, it's a neutral event, reflecting standard executive compensation practices and diversification.

Positives

• Chief Legal Officer Deborah Ann Miller realized significant value by exercising stock options at a low strike price of $6.89 and selling shares at market prices ranging from $89.98 to $92.50.

Negatives

• The sale of shares by a key executive, even under a 10b5-1 plan, represents a reduction in direct insider equity holdings.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This filing reports routine insider trading activity, which is common for executives to manage their compensation and diversify personal holdings. It does not provide specific insights into broader industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: May view the insider sale as a routine event under a 10b5-1 plan, which is common for executive compensation and personal financial management. It does not inherently signal a change in company fundamentals.

Key Dates

Recommendation

The filing details a pre-scheduled insider transaction where the Chief Legal Officer exercised stock options and sold shares. This is a routine event for executive compensation and personal financial planning, executed under a 10b5-1 plan, and does not provide new fundamental information about Nuvalent's operational performance or future prospects that would warrant a change in investment recommendation.

Keywords

Nuvalent, NUVL, Form 4, insider trading, stock options, executive compensation, Deborah Ann Miller, share sale, 10b5-1 plan